Cite
HARVARD Citation
Oyama, K. et al. (2021). Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial. European heart journal. pp. 1698-1706. [Online].